 |
|
| Parkinson's Disease Clinical Trials For posting and discussion of clinical trials related to Parkinson's Disease, and for the Parkinson Pipeline Project. All are welcome. |
| Reply |
|
|
Thread Tools | Display Modes |
08-24-2011, 07:14 AM
|
#1 | ||
|
|||
|
Member
|
Vernalis Initiates Phase I Trial of V81444 for Parkinson’s Disease
cisionwire, 24 August 2011 Vernalis plc today announces it has dosed the first subjects in a Phase I trial of V81444, its adenosine A receptor antagonist programme. A receptor antagonists are believed to have advantages over conventional dopaminergic strategies, in that they may be able to help restore motor function in patients with Parkinson’s Disease (PD), without the side effects commonly associated with today’s treatments. |
||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| new dopamine agonist | Parkinson's Disease | |||
| A2a receptor antagonist enters Phase 2b trials | Parkinson's Disease | |||
| dyskinesias: with or without agonist? | Parkinson's Disease | |||
| Phase II trials of A2a receptor antagonists | Parkinson's Disease | |||
| The agonist of defeat | Parkinson's Disease | |||
V81444, Phase 1 / A2A receptor agonist
Linear Mode
